Immunization, Independent Pharmacies and Labelling

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

Drug Topics

JULY 10, 2025

By tailoring your pharmacy to meet the needs of customers across both prescription and over-the-counter (OTC) products, you can transform your store into a long-term community destination for total health and wellness. Private-label brands allow you to deliver the same quality as larger name brands, often at a lower cost.

Health and Personal Care Stores

Health and Personal Care Stores Independent Pharmacies Labelling Specialty Pharmacies

Pharmacists Can Improve Insulin Management Through Counseling

Drug Topics

JULY 18, 2025

Simple techniques, such as color-coding or clearly labeling insulin pens and vials with a marker can help patients remember which insulin to use and when. Mealtime insulin must be taken close to eating, ranging from 30 minutes before to just after the meal, depending on the product.

Specialty Pharmacies

Specialty Pharmacies Compounding Independent Pharmacies Patient Care

Independent Pharmacy Innovation Spotlighted at McKesson ideaShare 2025

Pharmacy Times

JULY 14, 2025

McKesson ideaShare 2025 brought thousands of independent pharmacists, pharmacy owners, technicians, and industry leaders together in Nashville, Tennessee, shining a spotlight on innovation and advocacy in community pharmacy.

Independent Pharmacies

Independent Pharmacies Compounding Pharmacies Patient Care Hospitals

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Drug Topics

JUNE 12, 2025

Image Credit: sonyakamoz - stock.adobe.com "We have been conditioned to equate weight loss with health, and weight loss-resistant individuals are often labeled as failures,” Anat Yaskolka Meir, PhD, postdoctoral research fellow in the department of epidemiology at Harvard Chan School, said in a news release.

Compounding

Compounding Specialty Pharmacies Independent Pharmacies Immunization

Results Find SGLT2 Inhibitors Associated With Erythrocytosis

Drug Topics

JULY 7, 2025

2 One of the risks of SGLT2is has been an increase in hematocrit levels, ranging from 2.3% in clinical trials, according to a case series published in Endocrine Abstracts.

Compounding

Compounding Patient Care Specialty Pharmacies FDA

Donanemab-Azbt Receives FDA Label Update With New Dosing for Alzheimer Disease

Pharmacy Times

JULY 9, 2025

The FDA has approved an updated label with a new recommended titration dosing schedule for donanemab-azbt (Kisunla; Eli Lilly and Company) for once-monthly amyloid-targeting therapy for adults that experience early symptomatic Alzheimer disease (AD). million individuals in the United States aged 65 and older.

Labelling

Labelling FDA Compounding Pharmacies Independent Pharmacies

FDA Approves Mavyret for Treatment of Acute HCV Infection

Drug Topics

JUNE 12, 2025

The FDA approved a label expansion for glecaprevir/pibrentasvir (Mavyret) to treat acute hepatitis C virus (HCV) infection in patients 3 years of age and older with compensated cirrhosis or without cirrhosis, AbbVie announced in a release.

FDA

FDA Vaccines Labelling Specialty Pharmacies

FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1

Drug Topics

JULY 10, 2025

MK-8591A-051 is a randomized, active-controlled, open-label phase 3 study evaluating the safety, tolerability, and antiretroviral activity of a switch to doravirine/islatravir compared with continued baseline antiretroviral therapy.

FDA

FDA Vaccines Specialty Pharmacies Compounding

Mifepristone Reduces HbA1c in Patients With T2D, Hypercortisolism | ADA 2025

Drug Topics

JUNE 26, 2025

The study also showed the therapy’s safety profile was consistent with its current label. 1 Data from the study were presented at the American Diabetes Association’s 85th Scientific Sessions, which were held June 20-23 in Chicago, Illinois. No new side effects or adverse events were identified during the trial.

Compounding

Compounding Specialty Pharmacies Independent Pharmacies Insurance

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

JUNE 25, 2025

of YA with obesity were prescribed OMs—predominantly GLP-1s approved for adults but used off label for younger people. Despite the high prevalence of obesity among children and YA, OM utilization remains low,” wrote authors of the abstract. 1 In the final year of the analysis (2024), just 1.5% of adolescents and 5.7%

Compounding

Compounding Insurance Coverage Insurance Specialty Pharmacies

Procedure Shows Promise for Sustained Weight Loss After GLP-1 Therapy

Drug Topics

JUNE 25, 2025

The study is an open-label cohort trial aimed at evaluating the safety, tolerability, and early efficacy of Revita for patients who lost at least 15% or more of their total body weight with a recently discontinued GLP-1.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Specialty Pharmacies Independent Pharmacies

Hair Loss Therapy Shows Potential for Regeneration in Phase 2 Trial

Drug Topics

JUNE 17, 2025

After the randomized portion of the study, patients were eligible to enroll in an open-label extension study for 3 months to assess the long term safety of PP405. Patients applied the therapy or placebo once per day for 4 weeks and were followed for up to 12 weeks.

Specialty Pharmacies

Specialty Pharmacies Compounding Independent Pharmacies Immunization

Custom Private Labeling Of Vitamins For Independent Pharmacies

DiversifyRx

JANUARY 23, 2025

Offer your patients unique and highly effective vitamins they won’t find online or in the big box stores because they will be private labeled to your pharmacy’s name. Private labeling is one of the most effective and affordable strategies for distinguishing your pharmacy from the competition.

Independent Pharmacies

Independent Pharmacies Labelling Immunization

Pharmacy Technician Pulse

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

Pharmacists Can Improve Insulin Management Through Counseling

Trending Sources

Independent Pharmacy Innovation Spotlighted at McKesson ideaShare 2025

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Results Find SGLT2 Inhibitors Associated With Erythrocytosis

Donanemab-Azbt Receives FDA Label Update With New Dosing for Alzheimer Disease

FDA Approves Mavyret for Treatment of Acute HCV Infection

FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1

Mifepristone Reduces HbA1c in Patients With T2D, Hypercortisolism | ADA 2025

Obesity Medication Use Remains Low Among Children | ADA 2025

Procedure Shows Promise for Sustained Weight Loss After GLP-1 Therapy

Hair Loss Therapy Shows Potential for Regeneration in Phase 2 Trial

Custom Private Labeling Of Vitamins For Independent Pharmacies

Stay Connected